Comparing Elahere vs Zejula
| Elahere (mirvetuximab soravtansine) | Zejula (niraparib) |
|
|---|
| Elahere (mirvetuximab soravtansine) | Zejula (niraparib) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer. Elahere may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Peritoneal Cancer, Ovarian Cancer, Fallopian Tube Cancer. Zejula may also be used for purposes not listed in this medication guide. |
Related suggestions Ovarian Cancer
|
|||||||
| More about Elahere (mirvetuximab soravtansine) | More about Zejula (niraparib) | ||||||||
| Ratings & Reviews | |||||||||
|
Elahere has an average rating of 8.1 out of 10 from a total of 10 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 10% reported a negative effect. |
Zejula has an average rating of 6.4 out of 10 from a total of 58 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 28% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Elahere side effects |
View all Zejula side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Elahere prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
|
||||||||
| Brand Names | |||||||||
|
N/A |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
115.2 hours |
51 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 146 drugs are known to interact with Elahere:
|
A total of 607 drugs are known to interact with Zejula:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 14, 2022 |
March 27, 2017 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.